Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy.

@article{Akhtari2016PrimaryCB,
  title={Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy.},
  author={Mani Akhtari and Jay P Reddy and Chelsea C Pinnix and Pamela K. Allen and Eleanor Marshall Osborne and Jillian R. Gunther and Sarah A Milgrom and Grace Li Smith and Christine F. Wogan and Nathan H Fowler and Maria Alma Rodriguez and Bouthaina Shbib Dabaja},
  journal={Leukemia & lymphoma},
  year={2016},
  volume={57 1},
  pages={34-8}
}
Primary cutaneous B cell lymphomas (PCBCL) are rare; although data on outcomes and treatment are limited, traditionally they have been treated with radiation doses in excess of 24 Gy. We retrospectively identified and reviewed all cases of PCBCL treated at our institution from 2002-2014. Thirty-nine patients with PCBCL (42 lesions) were identified. Radiation was the only treatment for most patients. All lesions had a complete response and none had in-field failures; seven patients had out-of… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…